AISHA RAFAT: Open Payments
NPI 1447934211 · BOLINGBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $133 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: MOUNJARO, TRELEGY ELLIPTA, REXULTI, BREZTRI, Wegovy, OTEZLA.
Industry payments across IL — which companies pay providers there.
